FIGURE

FIGURE 5

ID
ZDB-FIG-211209-56
Publication
Li et al., 2021 - Attractin Participates in Schizophrenia by Affecting Testosterone Levels
Other Figures
All Figure Page
Back to All Figure Page
FIGURE 5

Clinical data show the abnormal serum testosterone level of mental disorder patients. We collected the medical records of patients with mental disorder in the hospital. Among 2,579 male patients (A) and 3,926 female patients (C) aged 20–49 years, the testosterone level in their serum was tested. Among the patients over the age of 50, the proportion of abnormal testosterone levels among 1,009 men (B) suffering from anxiety, insomnia, and depression was significantly increased (E–G), but among 1,741 women (D) suffering from anxiety, insomnia, and depression, the proportion of abnormal testosterone levels is significantly reduced. (E) For five male patients with schizophrenia who are known to have ATRN mutations in the clinic, their lower serum testosterone levels are more than that of schizophrenia patients without ATRN mutations. (F) For nine female schizophrenia patients with ATRN mutations, serum testosterone level was higher than that of the schizophrenia patients without ATRN mutations. Chi-test (Fisher’s exact test). *p < 0.05; **p < 0.01; ***p < 0.001; ns, no significance (p > 0.05).

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Front Cell Dev Biol